🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Nanjing
Clinical trial register · China

Clinical Trials in Nanjing, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
The First Affiliated Hospital with Nanjing Medical University201 The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School89 Nanjing First Hospital, Nanjing Medical University68 The Second Hospital of Nanjing Medical University32 Nanjing Medical University30
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Nanjing

1193 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
The Impact of Ultrasound-Guided Superficial and Deep Paravertebral Nerve Blocks at the Superior Costotransverse Ligament on Hemodynamics During the Induction Phase of Thoracoscopic Lung Lobectomy: A Multicenter, Double-Blind, Randomized Controlled Trial
NCT06841822Thoracic Paravertebral Block, Anesthesia Induction, Hypotension on Induction
Nanjing First Hospital, Nanjing Medical University
Not applicable
168
Nanjing
2025-05-25
Recruiting
The CD19/CD20 Dual-Target in Vivo CAR-T Lentiviral Product in the Treatment of Relapsed/Refractory B-cell Malignancies
NCT07002112Relapsed/Refractory B-cell Malignancies
The First Affiliated Hospital with Nanjing Medical University
Phase 1
30
Hefei, Beijing, Shijiazhuang, Zhengzhou, Wuhan, Nanjing
2025-05-23
Recruiting
Individualized Comprehensive Treatment for Advanced Hepatocellular Carcinoma
NCT06893887Hepatocellular Carcinoma(HCC)
Nanjing Tianyinshan Hospital
Not applicable
300
Nanjing
2025-05-22
Active, closed
This is a Multi-centre, Multi-drug, Platform Study in Chinese Participants Living With Obesity / Overweight
NCT07017179Obesity/Overweight
AstraZeneca
Phase 2
14
Jinan, Nanjing, Shanghai
2025-05-20
Recruiting
A Phase I Study of SIM0686 in Participants With Locally Advanced/Metastatic Solid Tumors
NCT07050459Locally Advanced Solid Tumors
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1
220
Beijing, Haerbin, Zhengzhou, Changsha, Nanjing, Jinan, Shanghai, Chengdu
2025-05-20
Recruiting
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
NCT06977581Asthma
Pfizer
Phase 2
252
Beijing, Guangzhou, Baotou, Hohhot, Najing, Nanjing, Xuzhou, Nanchang
2025-05-20
Recruiting
An Exploratory Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Antisynthetase Antibody Syndrome and Rheumatoid Arthritis
NCT06613490Antisynthetase Syndrome, Rheumatoid Arthritis
The First Affiliated Hospital with Nanjing Medical University
Phase EARLY_PHASE1
24
Nanjing
2025-05-20
Recruiting
Adebrelimab With Chemoradiotherapy and Surgery for G/GEJ
NCT06985602Gastroesophageal Adenocarcinoma, Gastric Adenocarcinoma
Jiangsu Cancer Institute & Hospital
Phase 2
30
Nanjing
2025-05-16
Recruiting
Nasopharyngeal Airway Combined With Nasal High-flow Oxygen Therapy During Painless Gastroscopy in Obesity Patients
NCT06966934Hypoxia, Obesity, Gastrostomy
Nanjing First Hospital, Nanjing Medical University
Not applicable
364
Nanjing
2025-05-14
Active, closed
Exploratory Clinical Study on Memory NK Cell Therapy for Advanced Metastatic Solid Tumors
NCT07274449Advanced Solid Cancers
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 1/2
6
Nanjing
2025-05-08
Recruiting
Targeted Anti-CEA CAR-T Immunotherapy for Advanced Lung Cancer
NCT06992583Advanced Lung Cancer
Chongqing Precision Biotech Co., Ltd
Phase 1
60
Nanjing
2025-05-08
By invitation
A Study of GD007 (Human iPSC-Exosome Liquid Dressing) for Safety and Dose-Finding in Moderate-Severe Intrauterine Adhesions
NCT07101484Moderate-Severe Intrauterine Adhesions
The First Affiliated Hospital with Nanjing Medical University
Not applicable
29
Nanjing
2025-05-04
Active, closed
Effects of Neuromuscular Electrical Stimulation Combined With Ultrasound on Stroke Patients With Sarcopenia
NCT07708597Stroke, Sarcopenia
Nanjing First Hospital, Nanjing Medical University
Not applicable
152
Nanjing
2025-05-01
Recruiting
Using 3D Kidney Model Based on Artificial Intelligence to Assist Partial Nephrectomy: A Prospective Validation Study
NCT07020169Renal Cell Cancer
Shao Pengfei
Not applicable
232
Nanjing
2025-05-01
Recruiting
A Study of Bemosubaiabimab Combined With Anlotinib and Radiotherapy and Chemotherapy for the Treatment of Oligometastatic Esophageal Cancer
NCT07455019Esophageal Cancer
The First Affiliated Hospital with Nanjing Medical University
Phase 2
28
Nanjing
2025-05-01
Not yet open
Mindfulness-Enhanced Dual-Task Training in PD-MCI
NCT06930742Mild Cognitive Impairment (MCI), Parkinson's Disease (PD)
Nanjing Mingzhou Rehabilitation Hospital
Not applicable
90
Nanjing
2025-05-01
Recruiting
A Prospective Study to Assess the Efficacy of IL-17 Inhibitors on Subclinical Enthesitis in Patients With Moderate to Severe Psoriasis Based on Power Doppler (PD) Ultrasonography (PDUS)
NCT06987292Psoriasis (PsO), Enthesitis, Psoriasis Arthritis, Secukinumab
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
50
Nanjing
2025-05-01
Recruiting
Inhaled Colistin to Prevent Ventilator-Associated Pneumonia in Patients With Acute Brain Injury
NCT06819462Ventilator-Associated Pneumonia (VAP), Inha'le'd
Southeast University, China
Not applicable
444
Nanjing
2025-04-27
Recruiting
Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors
NCT06414460Locally Advanced/Metastatic Solid Tumors
InSilico Medicine Hong Kong Limited
Phase 1/2
146
Beijing, Guangzhou, Nanjing, Shanghai
2025-04-25
Recruiting
Kidney-protective Intervention With Salt Substitute After Kidney Tumor Surgery
NCT07062952Kidney Tumors, CKD, Salt Substitute, Nephrectomy
Jinling Hospital, China
Not applicable
200
Nanjing
2025-04-24
Recruiting
VA Dual Sequential Therapy
NCT06929962Helicobacter Pylori Infection
The First Affiliated Hospital with Nanjing Medical University
Phase 4
600
Nanjing
2025-04-24
Active, closed
Phase II Study Evaluating the Efficacy and Safety of DR10624 Injection in MASLD and MetALD Subjects
NCT07024212MASLD
Zhejiang Doer Biologics Co., Ltd.
Phase 2
110
Hangzhou, Changchun, Nanjing
2025-04-22
Recruiting
Different Injection Speed on Local Anaesthetic Spread of ESPB
NCT06936904Erector Spinae Plane Block
Nanjing First Hospital, Nanjing Medical University
Not applicable
74
Nanjing
2025-04-21
Recruiting
A Study on the Application of NE Irrigation Fluid for Hemostasis in Flexible Ureteroscopic Lithotripsy: A Prospective Single-arm Interventional Study of Upper Urinary Tract Calculi.(NE: Norepinephrine)
NCT07786844Urolithiasis, Lithotripsy
Geriatric Hospital of Nanjing Medical University
Phase 1/2
55
Nanjing
2025-04-21
Recruiting
A Clinical Study on the Efficacy and Safety of Paclitaxel Polymeric Micelles and Cisplatin Combined With Cadonilimab as a Neoadjuvant Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma
NCT06356688Locally Advanced Esophageal Squamous Cell Carcinoma, Neoadjuvant Therapy
Sun Jing
Phase 2
30
Nanjing
2025-04-20
Recruiting
Homoharringtonine Plus Androgen Deprivation Therapy in the Neoadjuvant Treatment of Prostate Cancer: A Single-Arm Clinical Study
NCT07163910Prostate Cancer
baotai Liang
Phase 2
93
Nanjing
2025-04-20
Recruiting
Eradication of Helicobacter Pylori Improves Metabolic Syndrome Through Modulation of Gut Microbiota.
NCT07306988HELICOBACTER PYLORI INFECTIONS, Metabolic Syndrome
Nanjing First Hospital, Nanjing Medical University
Phase 4
120
Nanjing
2025-04-17
Active, closed
Chinese HCC Efficacy Evaluation, Response and Safety Study of TareSphere
NCT06900543Unresectable Hepatocellular Carcinoma
Chengdu New Radiomedicine Technology Co. LTD.
Phase 3
108
Fuzhou, Guangzhou, Zhengzhou, Wuhan, Nanjing, Shenyang, Xi’an, Chengdu
2025-04-15
Recruiting
Phase I Study of HSK41959 in Solid Tumors With MTAP Deletion
NCT06968572Advanced Solid Tumors
Haisco Pharmaceutical Group Co., Ltd.
Phase 1
245
Guiyang, Nanjing, Shanghai
2025-04-11
Recruiting
UB-VV400 in Combination With Rapamycin in Relapsed or Refractory B-cell Malignancies
NCT06743503Large B-cell Lymphoma
Nanjing IASO Biotechnology Co., Ltd.
Phase 1
70
Nanjing, Tianjin
2025-04-11
Recruiting
Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C
NCT06821503Advanced Pancreatic Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1/2
72
Beijing, Chongqing, Harbin, Zhengzhou, Wuhan, Nanjing, Nanchang, Shenyang
2025-04-11
Recruiting
18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis
NCT06937112Lung Cancers, Pancreatic Cancer, Neuroendocrine Tumors, Thyroid Cancer
Nanjing First Hospital, Nanjing Medical University
Observational
20
Nanjing
2025-04-10
Recruiting
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
NCT06726148Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Extensive-stage Small Cell Lung Cancer
Novartis Pharmaceuticals
Phase 1/2
280
Nanjing, Xian
2025-04-03
Recruiting
SIRT Versus cTACE for Unresectable HCC (CHANCE2506)
NCT06909708Unresectable Hepatocellular Carcinoma
Zhongda Hospital
Not applicable
108
Nanjing
2025-04-03
Recruiting
Universal Anti-CD70 CAR-T (CHT101) Cell Therapy for Relapsed Refractory Systemic Lupus Erythematosus
NCT06946485Systemic Lupus Erythematosus (SLE)
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase EARLY_PHASE1
15
Nanjing
2025-04-02
Recruiting
Effect of Remimazolam Sedation on Outcomes of Mechanically Ventilated Patients in the ICU
NCT07596589Remimazolam Besylate, Mechanically Ventilated ICU Patients, Sedation
Southeast University, China
Phase 3
80
Nanjing
2025-04-01
Not yet open
Effect of ADT and ARPI on Bone Loss of Patients with Prostate Cancer
NCT06838520Prostate Cancer (Adenocarcinoma)
The First Affiliated Hospital with Nanjing Medical University
Observational
200
Changzhou, Nanjing, Suzhou, Yangzhou
2025-04-01
Recruiting
Orelabrutinib Combined With Rituximab ± Lenalidomide in Response-Adapted Stratified Therapy for Untreated MZL
NCT07448324Marginal Zone Lymphoma(MZL)
The First Affiliated Hospital with Nanjing Medical University
Phase 2
50
Nanjing
2025-04-01
Not yet open
A Multicenter, Open-label, Prospective Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Participants With Suspected Recurrent Prostate Cancer After Radical Treatment
NCT06922929Prostate Cancer Recurrent
Yunhe Pharmaceutical (Tianjin) Co., Ltd
Phase 3
110
Beijing, Cangzhou, Wuhan, Yichang, Changsha, Nanjing, Suzhou, Taizhou
2025-04
Not yet open
Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Patients With Prostate Cancer.
NCT06922903Prostate Cancer
Yunhe Pharmaceutical (Tianjin) Co., Ltd
Phase 3
240
Beijing, Cangzhou, Wuhan, Yichang, Changsha, Nanjing, Suzhou, Taizhou
2025-04
Recruiting
Tislelizumab Combined With Anlotinib as Second-line Therapy in Thymoma and Thymic Carcinoma
NCT06838910Thymic Carcinoma, Thymoma
The First Affiliated Hospital with Nanjing Medical University
Phase 2
20
Nanjing
2025-03-31
Not yet open
CMTS4520 for Chronic Constipation in Adults
NCT06832137Constipation
The Second Hospital of Nanjing Medical University
Phase 1/2
100
Nanjing
2025-03-31
Active, closed
Effects of iGlarLixi Versus iGlar on Liver Fat Content in Patients With Type 2 Diabetes Mellitus Combined With Metabolic Dysfunction-associated Steatotic Liver Disease
NCT07274644Metabolic Dysfunction-Associated Steatotic Liver Disease, Diabetes Mellitus Type 2
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 4
36
Nanjing
2025-03-29
Recruiting
A Phase II/III Trial Comparing Transarterial Tirapazamine Embolization (TATE) With cTACE for Intermediate-stage Liver Cancer.
NCT06844357HCC
Zhejiang Raygene Pharmaceuticals Co., Ltd
Phase 2/3
300
Nanjing, Lishui
2025-03-27
Recruiting
Study on the Optimization of the Diagnostic Process for Chronic Rhinitis Using Nasal Allergen Provocation Test
NCT06999044Chronic Rhinitis
The First Affiliated Hospital with Nanjing Medical University
Observational
100
Nanjing
2025-03-24
Recruiting
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
NCT06914128MTAP-deleted Solid Tumors
Bayer
Phase 1/2
450
Beijing, Wuhan, Nanjing, Hangzhou
2025-03-21
Recruiting
Phase 3 Study of Human TH-SC01 Cell Injection for Treating Perianal Fistulas in Patients With Crohn's Disease
NCT06925594Crohn's Disease
Jiangsu Topcel-KH Pharmaceutical Co., Ltd.
Phase 3
228
Nanjing
2025-03-20
Recruiting
Real-World Study of PADN for the Treatment of PAH
NCT07039604Pulmonary Hypertension, Hypertension, Pulmonary Arterial
Pulnovo Medical (Wuxi) Co., Ltd.
Observational
200
Nanjing
2025-03-19
Recruiting
Clinical Study on Neoadjuvant Therapy of Homoharringtonine Combined With Androgen Deprivation for Prostate Cancer
NCT06834321Prostate CA
baotai Liang
Phase 2
96
Nanjing, Nantong
2025-03-19
Recruiting
Nocardia Rubra Cell Wall Skeleton in Combination With Prior Second- or Third-line Regimens for the Treatment of Potentially Hazardous Colorectal Cancer SD Status
NCT06356714Colorectal Cancer, Colorectal Neoplasms
Sun Jing
Phase 2
22
Nanjing
2025-03-15
Recruiting
A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis
NCT06869551Juvenile Psoriatic Arthritis
Bristol-Myers Squibb
Phase 3
60
Beijing, Chongqing, Guangzhou, Nanjing, Changchun, Hangzhou, Shanghai
2025-03-13
Active, closed
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
NCT06764485Metastatic Castration-resistant Prostate Cancer
Celgene
Phase 3
960
Hefei, Beijing, Fuzhou, Xiamen, Guangzhou, Huizhou, Changzhou, Nanjing
2025-03-13
Recruiting
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
NCT06641466Menstrual Migraine
Pfizer
Phase 3
723
Beijing, Chongqing, Shijiazhuang, Nanjing, Suzhou, Xi'an, Xianyang, Shanghai
2025-03-11
Active, closed
The Study of Postoperative Delirium and Glymphatic System Function in Cardiac Surgery
NCT06901479Postoperative Delirium (POD)
Nanjing First Hospital, Nanjing Medical University
Observational
200
Nanjing
2025-03-10
Not yet open
Postoperative Adjuvant Therapy for CT041 Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma Patients
NCT06857786Gastroesophageal Junction Adenocarcinoma, Gastric Adenocarcinoma
Peking University
Phase 1
48
Beijing, Nanjing
2025-03-10
By invitation
Effects of Different Exercises on Intrahepatic Lipid in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease
NCT06994871Metabolic Dysfunction-Associated Steatotic Liver Disease
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Not applicable
186
Nanjing
2025-03-09
Recruiting
Study of CMTS1215 Injection in Patients With Solid Tumors
NCT07556276Solid Tumor
The Second Hospital of Nanjing Medical University
Phase 1/2
20
Nanjing
2025-03-06
Recruiting
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
NCT06772623Non Small Cell Lung Carcinoma
AbbVie
Phase 1/2
252
Beijing, Fuzhou, Liuzhou, Zhengzhou, Wuhan, Changsha, Nanjing, Nanchang
2025-03-06
Recruiting
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
NCT06742996Mantle Cell Lymphoma, B Cell Lymphoma
BeOne Medicines
Phase 3
300
Beijing, Chongqing, Guangzhou, Harbin, Zhengzhou, Wuhan, Nanjing, Xuzhou
2025-03-05
Not yet open
Deep Sedation in Catheter Ablation of Atrial Fibrillation
NCT06836999Atrial Fibrillation, Atrial Fibrillation, Paroxysmal or Persistent, Deep Sedations, Conscious Sedation
The First Affiliated Hospital of Dalian Medical University
Not applicable
1,334
Hefei, Guangzhou, Nanjing, Suzhou, Nanchang, Dalian, Qingdao, Shanghai
2025-03-03
Not yet open
Effect of Digital Therapeutics for Cardiac Rehabilitation in Patients With Acute Myocardial Infarction
NCT06772337Acute Myocardial Infarction, Cardiac Rehabilitation
The First Affiliated Hospital with Nanjing Medical University
Not applicable
160
Nanjing
2025-03-01
Recruiting
A Multicenter Prospective Randomized Controlled Clinical Trial Comparing Constant (5%) Versus Sequential (5%-2%) Oxygen Concentration Embryo Culture Protocols in Assisted Reproductive Technology
NCT07050537Fertility Issues, Blastocyst IVF, Embryo Culture
The First Affiliated Hospital with Nanjing Medical University
Not applicable
980
Zhengzhou, Changzhou, Nanjing, Suzhou, Xi’an
2025-03-01
Not yet open
Risk Prediction Model of MACE in Patients With AMI Based on Multi-modal Machine Learning
NCT06767852Acute Myocardial Infarction
The First Affiliated Hospital with Nanjing Medical University
Observational
655
Nanjing
2025-03-01
Recruiting
Multimodal Phenotyping in Adolescent Inpatient Depression: An Observational Study
NCT07247344Adolescent, Major Depressive Disorder (MDD, Bipolar Disorder (BD)
Jiangsu Province Nanjing Brain Hospital
Observational
1,000
Nanjing
2025-03-01
Not yet open
Effectiveness of Ginkgo Diterpene Lactone Meglumine in Acute Ischemic Stroke
NCT06861426Acute Ischemic Stroke
Ying Gao
Observational
4,460
Lanzhou, Harbin, Zhengzhou, Nanjing, Xuzhou, Changchun, Jining, Xian
2025-03-01
Not yet open
The Safety and Efficacy of Intravenous EXG110 in Patients With Fabry Disease
NCT06819514Fabry Disease
Guangzhou Jiayin Biotech Ltd
Phase 1/2
16
Nanjing, Hangzhou
2025-03-01
Not yet open
IPSC-CMs Combined with LVAD or CABG for the Treatment of Heart Failure
NCT06866600Heart Failure, Heart Failure At NYHA Stage III or IV
HELP Therapeutics Co., Ltd.
Phase 1/2
40
Nanjing
2025-03
Recruiting
Serial Coronary CTA-based Plaque Progression Detection for Management of Coronary Heart Disease
NCT06843005Major Adverse Cardiovascular Events (MACE), Prevention, Coronary Artery Disease(CAD), CT Angiography
Zhang longjiang,MD
Not applicable
3,100
Nanjing
2025-02-28
Recruiting
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
NCT06780137Small Cell Lung Cancer
Merck Sharp & Dohme LLC
Phase 1/2
327
Beijing, Fuzhou, Nanjing, Shanghai, Chengdu, Hangzhou
2025-02-27
Recruiting
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
NCT06780670Prostate Cancer
Novartis Pharmaceuticals
Phase 2/3
443
Fuzhou, Wuhan, Nanjing, Shenyang, Xian, Chengdu, Beijing, Guangzhou
2025-02-27
Recruiting
SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors
NCT06873659Solid Tumor, Gastric Cancer, Liver Cancer
Qurgen Inc.
Phase 1
96
Beijing, Lanzhou, Guangzhou, Nanjing, Xi'an, Jinan, Shanghai, Hangzhou
2025-02-26
Recruiting
Gestational Lifestyle & Outcomes Wellness
NCT07263412GDM
The First Affiliated Hospital with Nanjing Medical University
Observational
1,000
Nanjing
2025-02-25
Recruiting
A Study on the Treatment of CTIT of the Efficacy and Safety With Romiplostim N01 Compared to Recombinant Human Interleukin-11
NCT06759636CTIT: Cancer Therapy Induced Thrombocytopenia
The First Affiliated Hospital with Nanjing Medical University
Phase 3
88
Nanjing
2025-02-24
Not yet open
CMTS4520-Assisted Washed Microbiota Transplantation for Chronic Constipation in Adults
NCT06832176Constipation
The Second Hospital of Nanjing Medical University
Phase 1/2
100
Nanjing
2025-02-20
Active, closed
CMTS4520 for Chronic Diarrhoea in Adults
NCT06839586Diarrhoea
The Second Hospital of Nanjing Medical University
Phase 1/2
100
Nanjing
2025-02-20
Active, closed
Evaluation of TQB3616 Capsules in a Phase II Clinical Trial for Recurrent/Metastatic Breast Cancer
NCT06702618Breast Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2
33
Bengbu, Jiangmen, Xingtai, Harbin, Luohe, Changsha, Nanjing, Nantong
2025-02-20
Not yet open
CMTS0929 for Inflammatory Bowel Disease
NCT06844708Inflammatory Bowel Disease (IBD)
The Second Hospital of Nanjing Medical University
Phase EARLY_PHASE1
12
Nanjing
2025-02-20
Not yet open
CMTS0929 for Clostridioides Difficile Infection
NCT06836427Clostridioides Difficile Infection
The Second Hospital of Nanjing Medical University
Phase EARLY_PHASE1
12
Nanjing
2025-02-20
Not yet open
CMTS4520-Assisted Washed Microbiota Transplantation for Chronic Diarrhoea in Adults
NCT06839599Diarrhea
The Second Hospital of Nanjing Medical University
Phase 1/2
100
Nanjing
2025-02-20
Recruiting
Clinical Study of Fasudil Hydrochloride and PD1 Inhibitor Combined With Androgen Deprivation in Neoadjuvant Therapy of Prostate Cancer
NCT06861192Prostate CA
baotai Liang
Phase 2/3
83
Nanjing
2025-02-16
Recruiting
Autologous Decidual-like Natural Killer Cells Therapy for Infertility or Adverse Pregnancy History
NCT06821685Abortion, Habitual, Infertility Unexplained, Embryo Implantation, Pre-Eclampsia
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 1
14
Nanjing
2025-02-13
Recruiting
Phase II Clinical Study of HDM1005 Injection in Obese Adults Without Diabetes Mellitus
NCT06886126Obesity
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 2
240
Nanjing
2025-02-07
Recruiting
Polymeric Micellar Paclitaxel for Metastatic Pancreatic Cancer
NCT06752811Pancreatic Cancer Metastatic
Shanghai Yizhong Pharmaceutical Co., Ltd.
Phase 3
416
Nanjing, Shanghai
2025-02-05
Recruiting
Washed Microbiota Transplantation Combined With Enteral Nutrition for Gastroptosis
NCT06837194Gastroptosis, Malnutrition
The Second Hospital of Nanjing Medical University
Observational
24
Nanjing
2025-02-01
Recruiting
A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth Sequencing
NCT07036731Non Muscle Invasive Bladder Cancer
The First Affiliated Hospital with Nanjing Medical University
Not applicable
428
Nanjing
2025-02-01
Recruiting
Impact of Pre-Ablation Prehabilitation on Clinical Outcomes and Cardiorespiratory Fitness in Atrial Fibrillation Patients
NCT07270757Atrial Fibrillation (AF)
Nanjing Medical University
Not applicable
100
Nanjing
2025-02-01
Not yet open
Evaluation of an Artificial Intelligence Model for the Prediction of Human Blastocyst Ploidy Without Invasive Procedures
NCT06762704The Focus is to Validate the Accuracy of a Non-invasive Artificial Intelligence Model for the Prediction of the Human Blastocyst Ploidy, Preimplantation Genetic Testing (PGT)
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
1,408
Hefei, Nanjing, Nanchang, Xi'an, Shanghai
2025-02
Recruiting
Clinical Study on the Effectiveness and Safety of Lenvatinib As Adjuvant Treatment for Patients with High-risk Recurrence of Hepatocellular Carcinoma After Surgery
NCT06762782Hepatocellular Carcinoma (HCC), Adjuvant Therapy in Patients with Hepatocellular Carcinoma (HCC) At High Risk of Recurrence After Curative Resection or Ablation
The First Affiliated Hospital with Nanjing Medical University
Phase 2
276
Nanjing
2025-02
Recruiting
Dynamic Prediction Model for Patients with Unresectable Biliary Malignancies Receiving Systemic Chemotherapy Combined with Immunotherapy: a Multicenter, Observational Study
NCT06849193Unresectable Biliary Tract Cancer, Dynamic Prediction Model, Immunotherapy
Zhongda Hospital
Observational
332
Nanjing
2025-01-31
Recruiting
Hypofractionated Radiation Fractionation in Breast Cancer Patients With Implant-Based Reconstruction
NCT06830083Breast Cancer
The First Affiliated Hospital with Nanjing Medical University
Not applicable
840
Nanjing
2025-01-30
Recruiting
Effect of Percutaneous Electrical Acupoint Stimulation on the Improvement of Incidence of Adverse Respiratory Events
NCT06772961Extubation, Respiratory Depression, Acupuncture Points, Hypoxia
Nanjing First Hospital, Nanjing Medical University
Not applicable
236
Nanjing
2025-01-25
Recruiting
PET/CT-Directed Free of Therapy for Metastatic RCC Patients With IMDC Favorable or Intermediate Risk
NCT07175480Renal Cell Carcinoma (RCC), Metastatic Renal Cell Carcinoma (mRCC)
Jinling Hospital, China
Phase 2
30
Nanjing
2025-01-24
Recruiting
Effects of Face Mask Continuous Positive Airway Pressure Vs. Noninvasive Ventilation Vs. High-flow Nasal Oxygen on Intubation-free Survival in Acute Hypoxemic Respiratory Failure: the TRIPOD Randomized Clinical Trial
NCT06795971Acute Hypoxemic Respiratory Failure, High-Flow Nasal Oxygen Therapy, Noninvasive Ventilation, Continuous Positive Airway Pressure (CPAP)
Southeast University, China
Not applicable
1,300
Nanjing
2025-01-23
Recruiting
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer
NCT06609005Advanced Metastatic Castration Resistant Prostate Cancer
Shenzhen Ionova Life Sciences Co., Ltd.
Phase 1/2
84
Beijing, Fuzhou, Foshan, Zhengzhou, Changsha, Nanjing, Nanchang, Shenyang
2025-01-23
Recruiting
9MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial Carcinoma
NCT06823427Urothelial Carcinoma, Urothelial Carcinoma Bladder, Urothelial Carcinoma Recurrent, Urothelial Carcinoma of the Renal Pelvis and Ureter
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 2
60
Changsha, Nanjing
2025-01-17
Recruiting
Evaluate the Efficacy and Safety of TTYP01 Tablets in Adolescents and Children With ASD
NCT06757504Autism Spectrum Disorder (ASD)
Shanghai Auzone Biological Technology Co., Ltd.
Phase 2
150
Beijing, Changsha, Chengdu, Nanjing, Tianjin
2025-01-13
Recruiting
A Study to Investigate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy With GenSci122 in Participants With Advanced Solid Tumors
NCT06772415Advanced Solid Tumor
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
163
Beijing, Zhengzhou, Changsha, Nanjing, Jinan, Shanghai, Tianjin
2025-01-08
Not yet open
Clinical Evaluation and Study of the Efficacy of a Centella Asiatica-Infused Facial Mask on Discosmetic Dermatosis
NCT06763367Rosacea, Acne, Centella, Melasma
Nanjing First Hospital, Nanjing Medical University
Not applicable
30
Nanjing
2025-01-08
Active, closed
Observing the Real-world Non-interventional Study of Abiraterone Acetate Tablets (II) in Treating Chinese Patients With Metastatic Prostate Cancer
NCT07721532Diagnosed With Metastatic Prostate Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
3,000
Nanjing
2025-01-08
Recruiting
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
NCT06712316Non-small Cell Lung Cancer
BioNTech SE
Phase 2/3
1,580
Baoding, Beijing, Changchun, Hangzhou, Jinan, Kunming, Nanjing, Shanghai
2025-01-07
Rows per page Showing 501–600 of 1193
Previous 4 5 6 7 8 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/nanjing?page=6

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1,193 of those studies with a site in Nanjing.

How many clinical trials are recruiting in Nanjing?

713 of the 1,193 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 232 have not yet opened recruitment, 216 are active but closed to new participants, and 32 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.